Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04338048 · ClinicalTrials.gov registry record
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
A clinical trial of ADPKD, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- 300
- Enrollment target
- 4
- Study locations
NCT04338048: Recruiting study of ADPKD, sponsored by Children's Hospital of Philadelphia.
NCT04338048 is a study of ADPKD that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 300 participants, above the 146-participant average among 3 other ADPKD trials with a reported enrollment target (105% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04338048, a study of ADPKD, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 4
- Study locations
Study Summary
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of renal failure. For several decades, ADPKD was regarded as an adult-onset disease. In the last decade, it has become more widely appreciated that the disease course begins in childhood. However, evidence-based guidelines on how to manage and approach children diagnosed with or at-risk for of ADPKD are lacking. Overall, there is insufficient data on the clinical course during childhood. The study intends to get more information on Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other hepato/renal fibrocystic diseases. Additionally, the study intends to expand web-based resources so anyone can learn about ADPKD or other hepato/renal fibrocystic diseases. Individuals diagnosed with the dominant form of a hepato/renal fibrocystic condition are invited to be in the study.
Primary Outcome
Our research is designed to expand the currently limited knowledge about Autosomal Dominant Polycystic Kidney Diseases (ADPKD). Our specific goal is to create a registry of clinical information about this set of diseases. This study has two parts, the clinical database (medical health information) and the educational part. In this study we want to build a registry with information about ADPKD to learn more about this disease. There will be an optional urine and/or blood collection.
Conditions Studied
Study Locations (4)
District of Columbia
- Children's National Hospital - Washington D.C.
Minnesota
- Mayo Clinic - Rochester
New York
- Cohen Children's Medical Center - New Hyde Park
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2030-10-30 |
What NCT04338048 shows while recruiting
NCT04338048 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 146-participant average among 3 other ADPKD trials with a reported enrollment target (105% higher).
The record links to 1 condition, with ADPKD appearing as the primary indexed condition, and to 0 interventions.
NCT04338048 reports a single indexed study location in District of Columbia, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT04338048 about?
NCT04338048 is a clinical study titled "Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study". Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of renal failure. For several decades, ADPKD was regarded as an adult-onset disease. In the last decade, it has become more widely appreciated that the disease course begins in childhood. However, evidence-based gu...
What is the current status of trial NCT04338048?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2019-10-10. Estimated completion is 2030-10-30.
What conditions does trial NCT04338048 study?
This clinical trial studies the following conditions: ADPKD.
Who is sponsoring clinical trial NCT04338048?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04338048 being conducted?
This trial has 4 study locations across District of Columbia, Minnesota, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADPKD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI